Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.
Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Articles by Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Latest Updated Articles
- Clinical Efficacy: A Cost Containment Weapon for the 21st Century
Published: August 18th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Shifts in Colorectal Cancer Screening Trends After COVID-19
4
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
5
